바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.66 No.5
Citation Share

A Case of Docetaxel Induced Subacute Cutaneous Lupus Erythematosus

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2009, v.66 no.5, pp.380-384






& (2009). A Case of Docetaxel Induced Subacute Cutaneous Lupus Erythematosus. Tuberculosis & Respiratory Diseases, 66(5), 380-384.
  • Downloaded
  • Viewed
PDF Download

Abstract

Drug-induced subacute cutaneous lupus erythematosus (SCLE) is associated with use of the following classes of medications: anti-hypertensives, anti-cholesterolemia, anti-psychotics, and anti-inflammatory drugs. Docetaxel is an anti-neoplastic agent, which is widely used for treatment of non-small cell lung cancer. Few cases of docetaxel-induced SCLE have been reported in the medical literature. Here, we report the case of a 58-year-old female patient who developed drug-induced SCLE after administration of docetaxel. After 4 cycles of chemotherapy with docetaxel and cisplatin, erythematous skin eruptions developed on the patient’s face. Skin biopsies of the eruptions were remarkable for interfacing dermatitis with basement membrane thickening. Immunofluorescent study revealed characteristic features of SCLE, including granular deposition of IgM, C3, and apoptotic bodies along the basement membrane. The skin eruptions resolved gradually after cessation of drug and with the use of topical corticosteroids.

keywords
Subacute cutaneous lupus erythematosus, Drug-induced lupus erythematosus, Non-small-cell lung carcinoma, Docetaxel

Reference

1.

Chen M, Crowson AN, Woofter M, Luca MB, Magro CM. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J Rheumatol 2004;31:818-20.

2.

Crowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 2001;28:1-23.

3.

Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res 2009;301:99-105.

4.

Vasoo S. Drug-induced lupus: an update. Lupus 2006;15:757-61.

5.

Sontheimer RD, Henderson CL, Grau RH. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res 2009;301:65-70.

6.

Uetrecht J. Current trends in drug-induced autoimmunity. Autoimmun Rev 2005;4:309-14.

7.

Rubin RL. Drug-induced lupus. Toxicology 2005;209:135-47.

8.

Kretz-Rommel A, Rubin RL. Disruption of positive selection of thymocytes causes autoimmunity. Nat Med 2000;6:298-305.

9.

Stollar BD, Stephenson F. Apoptosis and nucleosomes. Lupus 2002;11:787-9.

10.

Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK. Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine. Mol Pharmacol 2000;58:207-16.

11.

Dasanu CA, Alexandrescu DT. Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer. South Med J 2008;101:1161-2.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy